Delivery Order SPE2DB22D2214-SPE2DB25FS3SE
Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract has a firm fixed price of $2,531.46 and a completion date of August 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical supplies to support the healthcare needs of military treatment facilities and other federal healthcare providers. This contract...
- This is a delivery order worth $1,383.12 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML pharmaceutical products. The contract has a final completion date of September 24, 2024 and uses a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a $1,118.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL infusion bottles (150 mL) with an ultimate completion date of January 5, 2026. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- This is a $1,687.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of VISIPAQUE 320 MG/ML infusion bottles, with a completion date of July 23, 2024. The contract was awarded on July 22, 2024, and is a firm fixed-price agreement. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML medical products. The $5,906.74 award has a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,237.92, is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract is a delivery order placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product, with a total ceiling value of $12,222.24 and a period of performance through March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,299.90 to AmerisourceBergen Drug Corp for the supply of VISIPAQUE 320 MG/ML in 100ML bottles. The contract is a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, and was awarded on January 30, 2026. This award was not set aside for small businesses or other designated categories, indicating it was awarded through full and open competition. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,475.92 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,079.84 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in a 100 ml bottle on January 23, 2026. This firm fixed-price delivery order, with completion scheduled for January 26, 2026, represents a small-value pharmaceutical procurement issued under a larger indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through open...